140 related articles for article (PubMed ID: 16444284)
1. Preservation of ovarian function by ovarian shielding when undergoing total body irradiation for hematopoietic stem cell transplantation: a report of two successful cases.
Nakagawa K; Kanda Y; Yamashita H; Hosoi Y; Oshima K; Ohtomo K; Ban N; Yamakawa S; Nakagawa S; Chiba S
Bone Marrow Transplant; 2006 Mar; 37(6):583-7. PubMed ID: 16444284
[TBL] [Abstract][Full Text] [Related]
2. Total body irradiation prior to bone marrow transplantation--the experience of the Institute of Oncology Prof. Dr. Al. Trestioreanu Bucharest.
Anghel R; Matache G; Vasile M; Matache RI; Oprea L; Popa R; Sucitu A; Costandache N; Bărbulescu I; Colita D; Varady Z; Tanase A; Moicean A; Arion C; Colita A; Dumitrache L
J BUON; 2006; 11(2):167-74. PubMed ID: 17318966
[TBL] [Abstract][Full Text] [Related]
3. Results of hematopoietic stem cell transplantation after treatment with different high-dose total-body irradiation regimens in five Dutch centers.
van Kempen-Harteveld ML; Brand R; Kal HB; Verdonck LF; Hofman P; Schattenberg AV; van der Maazen RW; Cornelissen JJ; Eijkenboom WM; van der Lelie JP; Oldenburger F; Barge RM; van Biezen A; Vossen JM; Noordijk EM; Struikmans H
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1444-54. PubMed ID: 18294781
[TBL] [Abstract][Full Text] [Related]
4. Ovarian shielding allows ovarian recovery and normal birth in female hematopoietic SCT recipients undergoing TBI.
Nakagawa K; Kanda Y; Yamashita H; Nakagawa S; Sasano N; Ohtomo K; Oshima K; Kumano K; Ban N; Nannya Y; Kurokawa M; Chiba S
Bone Marrow Transplant; 2008 Nov; 42(10):697-9. PubMed ID: 18695667
[No Abstract] [Full Text] [Related]
5. Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia.
Huck K; Laws HJ; Meisel R; Traeger A; Bernbeck B; Schonberger S; Stackelberg VA; Pape H; Dilloo D
Haematologica; 2006 May; 91(5 Suppl):ECR07. PubMed ID: 16709515
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric evaluation of ovaries and pelvic bones associated with clinical outcomes in patients receiving total body irradiation with ovarian shielding.
Akahane K; Shirai K; Wakatsuki M; Suzuki M; Hatanaka S; Takahashi Y; Kawahara M; Ogawa K; Takahashi S; Oyama-Manabe N; Ashizawa M; Kimura SI; Kako S; Kanda Y
J Radiat Res; 2021 Sep; 62(5):918-925. PubMed ID: 34350969
[TBL] [Abstract][Full Text] [Related]
7. Updated Clinical Outcomes of Hematopoietic Stem Cell Transplantation Using Myeloablative Total Body Irradiation with Ovarian Shielding to Preserve Fertility.
Ashizawa M; Akahoshi Y; Nakano H; Kawamura S; Takeshita J; Yoshino N; Misaki Y; Yoshimura K; Gomyo A; Tamaki M; Kusuda M; Kameda K; Wada H; Kawamura K; Sato M; Terasako-Saito K; Tanihara A; Kimura SI; Nakasone H; Kako S; Akahane K; Wakatsuki M; Shirai K; Kanda Y
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2461-2467. PubMed ID: 31394267
[TBL] [Abstract][Full Text] [Related]
8. Renal dysfunction after total-body irradiation. Significance of selective renal shielding blocks.
Igaki H; Karasawa K; Sakamaki H; Saito H; Nakagawa K; Ohtomo K; Tanaka Y
Strahlenther Onkol; 2005 Nov; 181(11):704-8. PubMed ID: 16254705
[TBL] [Abstract][Full Text] [Related]
9. Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.
Okuda S; Terasako K; Oshima K; Sato M; Nakasone H; Kako S; Yamazaki R; Tanaka Y; Tanihara A; Higuchi T; Nishida J; Kanda Y
Am J Hematol; 2009 Mar; 84(3):167-9. PubMed ID: 19195036
[TBL] [Abstract][Full Text] [Related]
10. Eye shielding during total body irradiation for bone marrow transplantation in children transplanted for a hematological disorder: risks and benefits.
van Kempen-Harteveld ML; van Weel-Sipman MH; Emmens C; Noordijk EM; van der Tweel I; Révész T; Struikmans H; Kal HB; van der Does-van den Berg A; Vossen JM
Bone Marrow Transplant; 2003 Jun; 31(12):1151-6. PubMed ID: 12796795
[TBL] [Abstract][Full Text] [Related]
11. A myeloablative conditioning regimen for patients with impaired cardiac function undergoing allogeneic stem cell transplantation: reduced cyclophosphamide combined with etoposide and total body irradiation.
Yoshimi A; Nannya Y; Sakata-Yanagimoto M; Oshima K; Takahashi T; Kanda Y; Motokura T; Chiba S; Kurokawa M
Am J Hematol; 2008 Aug; 83(8):635-9. PubMed ID: 18506704
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
13. Final height and gonad function after total body irradiation during childhood.
Couto-Silva AC; Trivin C; Esperou H; Michon J; Baruchel A; Lemaire P; Brauner R
Bone Marrow Transplant; 2006 Sep; 38(6):427-32. PubMed ID: 16878146
[TBL] [Abstract][Full Text] [Related]
14. Ovarian function after allogeneic hematopoietic stem cell transplantation in children and young adults given 8-Gy total body irradiation-based reduced-toxicity myeloablative conditioning.
Komori K; Hirabayashi K; Morita D; Hara Y; Kurata T; Saito S; Tanaka M; Yanagisawa R; Sakashita K; Koike K; Nakazawa Y
Pediatr Transplant; 2019 May; 23(3):e13372. PubMed ID: 30714283
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of pituitary-gonadal function to evaluate short-term effects of ablative chemotherapy or total body irradiation with autologous or allogenic marrow transplantation in post-menarcheal female patients.
Chatterjee R; Mills W; Katz M; McGarrigle HH; Goldstone AH
Bone Marrow Transplant; 1994 May; 13(5):511-7. PubMed ID: 8054904
[TBL] [Abstract][Full Text] [Related]
16. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
17. Total-body irradiation--role and indications: results from the German Registry for Stem Cell Transplantation (DRST).
Heinzelmann F; Ottinger H; Müller CH; Allgaier S; Faul C; Bamberg M; Belka C
Strahlenther Onkol; 2006 Apr; 182(4):222-30. PubMed ID: 16622624
[TBL] [Abstract][Full Text] [Related]
18. Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies: Experience from the European Group for Blood and Marrow Transplantation.
Belkacémi Y; Labopin M; Hennequin C; Hoffstetter S; Mungai R; Wygoda M; Lundell M; Finke J; Aktinson C; Lorchel F; Durdux C; Basara N
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):544-51. PubMed ID: 17141976
[TBL] [Abstract][Full Text] [Related]
19. Low toxicity of a conditioning with 8-Gy total body irradiation, fludarabine and cyclophosphamide as preparative regimen for allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies.
Yanagisawa R; Nakazawa Y; Sakashita K; Tanaka M; Shikama N; Kamijo T; Shiohara M; Koike K
Pediatr Transplant; 2009 Sep; 13(6):737-45. PubMed ID: 19207225
[TBL] [Abstract][Full Text] [Related]
20. Stem cell transplantation nephropathy: a report of six cases.
Kersting S; Verdonck LF
Biol Blood Marrow Transplant; 2007 Jun; 13(6):638-43. PubMed ID: 17531773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
